Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO Guidelines Committee

doi:10.1016/j.annonc.2020.11.008

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO Guidelines Committee

Peninsula Medical School

Ludwig Maximilian University of Munich
Ospedale San Giovanni
Hospices civils de Lyon
Universite Claude Bernard Lyon 1
Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo
University of Amsterdam
Heidelberg University
University of Melbourne
Lund University

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	298-308
Number of pages	11
Journal	Annals of Oncology
Volume	32
Issue number	3
DOIs	https://doi.org/10.1016/j.annonc.2020.11.008
Publication status	Published - Mar 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology
Oncology

Keywords

antibody
chemotherapy
follicular lymphoma
lenalidomide
radiotherapy

Access to Document

10.1016/j.annonc.2020.11.008

Cite this

@article{3c430f4b0cbb4e8388219564d675e1f2,

title = "Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",

keywords = "antibody, chemotherapy, follicular lymphoma, lenalidomide, radiotherapy",

author = "\{ESMO Guidelines Committee\} and M. Dreyling and M. Ghielmini and S. Rule and G. Salles and M. Ladetto and Tonino, \{S. H.\} and K. Herfarth and Seymour, \{J. F.\} and M. Jerkeman",

year = "2021",

month = mar,

doi = "10.1016/j.annonc.2020.11.008",

language = "English",

volume = "32",

pages = "298--308",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "3",

}

TY - JOUR

T1 - Newly diagnosed and relapsed follicular lymphoma

T2 - ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

AU - ESMO Guidelines Committee

AU - Dreyling, M.

AU - Ghielmini, M.

AU - Rule, S.

AU - Salles, G.

AU - Ladetto, M.

AU - Tonino, S. H.

AU - Herfarth, K.

AU - Seymour, J. F.

AU - Jerkeman, M.

PY - 2021/3

Y1 - 2021/3

KW - antibody

KW - chemotherapy

KW - follicular lymphoma

KW - lenalidomide

KW - radiotherapy

UR - https://www.scopus.com/pages/publications/85102153138

U2 - 10.1016/j.annonc.2020.11.008

DO - 10.1016/j.annonc.2020.11.008

M3 - Article

C2 - 33249059

AN - SCOPUS:85102153138

SN - 0923-7534

VL - 32

SP - 298

EP - 308

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

UN SDGs

ASJC Scopus subject areas

Keywords

Access to Document

Other files and links

Cite this